News
(2)April 2026
PMVP files Annual Report Summary; financial data and guidance unavailable
# ❓ What This Document Is This document is designated as an ARS (Annual Report Summary) for PMV Pharmaceuticals, Inc. (PMVP). ARS filings are typically used to provide a high-level, summary view of a company's annual performance, intended to give investors a quick overview of the most material infor
PMVP shareholders vote on governance, chair transition, and compensation proposals
# 📄 What This Document Is 📜 This document is a Proxy Statement (Form DEF 14A). Think of it as the official rulebook for an annual shareholder meeting. It was filed by PMV Pharmaceuticals, Inc. to ensure every stockholder knows exactly what is going to be voted on and how to participate. The main g
Peers in Biotechnology
Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.